OTTAWA--Canadian Prime Minister Justin Trudeau said Thursday that officials in Ottawa and Washington are in talks about alleviating the fallout from 25% on certain sectors.
Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback